Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women

This study is ongoing, but not recruiting participants.

Study NCT01230814 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on October 28, 2010. Last Updated on May 16, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Trichomoniasis
Candidiasis
Bacterial Vaginosis

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Placebo

Additional drug interventions recognized in this trial

Clotrimazole
Metronidazole
Miconazole

More general drug interventions related to this trial

Sponsors listed in this trial